This antibody was purified from hybridoma (clone MIH8) supernatant using protein A agarose. This hybridoma was established by fusion of mouse myeloma cell SP2/0 with DBA/2 mouse splenocyte immunized with full-length human CTLA-4 transfected p815 cells.
Target:
CD152
Application Dilute:
FCM: 10-20 µg/mL
* VAT and and shipping costs not included. Errors and price changes excepted